Concepedia
Statistics
Publications
12
Citations
563
H-Index
Active since
1999
Affiliations
Wilex (Germany)(Current)
Technical University of Munich
TUM Klinikum
Ludwig-Maximilians-Universität München
Technische Universität Dresden
Bernd Muehlenweg is an author at Wilex (Germany) specializing in molecular oncology, oncology, and medicine.
Publications per year
1999–2010
The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin 1 1Edited by A. R. Fersht
M.P. Coles, Tammo Diercks, Bernd Muehlenweg et al. · Journal of Molecular Biology · 1999 · 88 citations
Life Sciences, Biochemistry, Biophysics +14
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1
Buddy Setyono-Han, Jörg Stürzebecher, Wolfgang A. Schmalix et al. · Thrombosis and Haemostasis · 2005 · 85 citations
Medicine, Oncology, Pharmacology +14
Inhibition of the invasion capacity of carcinoma cells by WX‐UK1, a novel synthetic inhibitor of the urokinase‐type plasminogen activator system
Suna Ertongur, Stephan Lang, Brigitte Mack et al. · International Journal of Cancer · 2004 · 61 citations · Full text
Medicine, Oncology, Pharmacology +17
High‐affinity urokinase‐derived cyclic peptides inhibiting urokinase/urokinase receptor‐interaction: effects on tumor growth and spread
Sumito Sato, Charlotte Kopitz, Wolfgang A. Schmalix et al. · FEBS Letters · 2002 · 60 citations · Full text
Medicine, Oncology, Pharmacology +16
Interaction of plasminogen activator inhibitor type‐1 (PAI‐1) with vitronectin
Nuria Arroyo de Prada, Florian R. Schroeck, Eva‐Kathrin Sinner et al. · European Journal of Biochemistry · 2002 · 51 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
1–5 of 12